Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line

British Journal of Haematology

Volumn 130, Issue 6, 2005, Pages 878-889

  Minuzzo, Sonia ^a   Indraccolo, Stefano ^a,b   Tosello, Valeria ^a   Piovan, Erich ^a   Cabrelle, Anna ^a   Trentin, Livio ^a   Semenzato, Giampietro ^a   Amadori, Alberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Adenoviral vector; B cell receptor; CD79b; Chronic lymphocytic leukaemia; Gene transfer

Indexed keywords

AZATHIOPRINE; B LYMPHOCYTE RECEPTOR; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN M; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; MITOXANTRONE; PREDNISONE; CANCER ANTIBODY; CD79 ANTIGEN; CD79B PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURFACE PROPERTY; SYNTHESIS; UPREGULATION; ADENOVIRUS; BLOOD; CANCER STAGING; CELL CULTURE; GENE VECTOR; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; MIDDLE AGED; PATHOLOGY;

ADENOVIRIDAE; AGED; AGED, 80 AND OVER; ANTIBODIES, NEOPLASM; ANTIGENS, CD; ANTIGENS, CD79; FEMALE; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN M; IMMUNOPHENOTYPING; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, ANTIGEN, B-CELL; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 27244433608     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05699.x     Document Type: Article

References (30)

1. Alfarano A. Indraccolo S. Circosta P. Minuzzo S. Vallario A. Zamarchi R. Fregonese A. Calderazzo F. Faldella A. Aragno M. Camaschella C. Amadori A. Caligaris-Cappio F. ( 1999) An alternatively spliced form of CD79b gene may account for altered B- cell receptor expression in B-chronic lymphocytic leukemia. Blood, 93, 2327 2335.
2. Caligaris-Cappio F. Ghia P. ( 2004) The nature and origin of the B-chronic lymphocytic leukemia cell: a tentative model. Hematology/Oncology Clinics of North America, 18, 849 862, viii.
3. Cantwell M.J. Sharma S. Friedmann T. Kipps T.J. ( 1996) Adenovirus vector infection of chronic lymphocytic leukemia B cells. Blood, 88, 4676 4683.
4. Coppola V. Veronesi A. Indraccolo S. Calderazzo F. Mion M. Minuzzo S. Esposito G. Mauro D. Silvestri B. Gallo P. Falagiani P. Amadori A. Chieco-Bianchi L. ( 1998) Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. IV. Differential activation of human Th1 and Th2 lymphocytes and influence of the atopic status on lymphoma development. Journal of Immunology, 160, 2514 2522.
5. Costa T.E. Franke R.R. Sanchez M. Misulovin Z. Nussenzweig M.C. ( 1992) Functional reconstitution of an immunoglobulin antigen receptor in T cells. Journal of Experimental Medicine, 175, 1669 1676.
6. DeFranco A.L. ( 1993) Structure and function of the B cell antigen receptor. Annual Review of Cell Biology, 9, 377 410.
7. Ghia P. Guida G. Stella S. Gottardi D. Geuna M. Strola G. Scielzo C. Caligaris-Cappio F. ( 2003) The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood, 101, 1262 1269.
8. Gong S. Nussenzweig M.C. ( 1996) Regulation of an early developmental checkpoint in the B cell pathway by Ig beta. Science, 272, 411 414.
9. Grupp S.A. Mitchell R.N. Schreiber K.L. McKean D.J. Abbas A.K. ( 1995) Molecular mechanisms that control expression of the B lymphocyte antigen receptor complex. Journal of Experimental Medicine, 181, 161 168.
10. Hamblin T.J. Oscier D.G. ( 1997) Chronic lymphocytic leukaemia: the nature of the leukaemic cell. Blood Reviews, 11, 119 128.
11. He T.C. Zhou S. da Costa L.T. Yu J. Kinzler K.W. Vogelstein B. ( 1998) A simplified system for generating recombinant adenoviruses. Proceedings of the National Academy of Sciences United States of America, 95, 2509 2514.
12. Hombach J. Tsubata T. Leclercq L. Stappert H. Reth M. ( 1990) Molecular components of the B-cell antigen receptor complex of the IgM class. Nature, 343, 760 762.
13. Huang M.R. Olsson M. Kallin A. Pettersson U. Totterman T.H. ( 1997) Efficient adenovirus-mediated gene transduction of normal and leukemic hematopoietic cells. Gene Therapy, 4, 1093 1099.
14. Indraccolo S. Minuzzo S. Zamarchi R. Calderazzo F. Piovan E. Amadori A. ( 2002) Alternatively spliced forms of Igalpha and Igbeta prevent B cell receptor expression on the cell surface. European Journal of Immunology, 32, 1530 1540.
15. Lankester A.C. van Schijndel G.M. van der Schoot C.E. van Oers M.H. van Noesel C.J. van Lier R.A. ( 1995) Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells. Blood, 86, 1090 1097.
16. Matutes E. Polliack A. ( 2000) Morphological and immunophenotypic features of chronic lymphocytic leukemia. Reviews in Clinical and Experimental Hematology, 4, 22 47.
17. Minegishi Y. Coustan-Smith E. Rapalus L. Ersoy F. Campana D. Conley M.E. ( 1999) Mutations in Igalpha (CD79a) result in a complete block in B-cell development. Journal of Clinical Investigation, 104, 1115 1121.
18. Payelle-Brogard B. Magnac C. Alcover A. Roux P. Dighiero G. ( 2002) Defective assembly of the B-cell receptor chains accounts for its low expression in B-chronic lymphocytic leukaemia. British Journal of Haematology, 118, 976 985.
19. Piovan E. Bonaldi L. Indraccolo S. Tosello V. Menin C. Comacchio F. Chieco-Bianchi L. Amadori A. ( 2003) Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation. Leukemia, 17, 1643 1649.
20. Reth M. ( 1992) Antigen receptors on B lymphocytes. Annual Review in Immunology, 10, 97 121.
21. Sanchez M. Misulovin Z. Burkhardt A.L. Mahajan S. Costa T. Franke R. Bolen J.B. Nussenzweig M. ( 1993) Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta. Journal of Experimental Medicine, 178, 1049 1055.
22. Semichon M. Merle-Beral H. Lang V. Bismuth G. ( 1997) Normal Syk protein level but abnormal tyrosine phosphorylation in B-CLL cells. Leukemia, 11, 1921 1928.
23. Stacchini A. Aragno M. Vallario A. Alfarano A. Circosta P. Gottardi D. Faldella A. Rege-Cambrin G. Thunberg U. Nilsson K. Caligaris-Cappio F. ( 1999) MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leukemia Research, 23, 127 136.
24. Takahashi S. Rousseau R.F. Yotnda P. Mei Z. Dotti G. Rill D. Hurwitz R. Marini F. Andreeff M. Brenner M.K. ( 2001) Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes. Human Gene Therapy, 12, 659 670.
25. Tarlinton D. ( 1997) Antigen presentation by memory B cells: the sting is in the tail. Science, 276, 374 375.
26. Thompson A.A. Talley J.A. Do H.N. Kagan H.L. Kunkel L. Berenson J. Cooper M.D. Saxon A. Wall R. ( 1997) Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia. Blood, 90, 1387 1394.
27. Torres R.M. Flaswinkel H. Reth M. Rajewsky K. ( 1996) Aberrant B cell development and immune response in mice with a compromised BCR complex. Science, 272, 1802 1804.
28. Vuillier F. Dumas G. Magnac C. Prevost M.C. Lalanne A.I. Oppezzo P. Melanitou E. Dighiero G. Payelle-Brogard B. ( 2005) Lower levels of surface B-cell receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the mu and CD79a chains. Blood, 105, 2933 2940.
29. Wattel E. Vanrumbeke M. Abina M.A. Cambier N. Preudhomme C. Haddada H. Fenaux P. ( 1996) Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies. Leukemia, 10, 171 174.
30. Zomas A.P. Matutes E. Morilla R. Owusu-Ankomah K. Seon B.K. Catovsky D. ( 1996) Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b). Leukemia, 10, 1966 1970.